Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 25 ... Expedia.com, Aurora Fashions, Papa John's, CareerBuilder.com, Gannett Co., Inc., The Leukemia & Lymphoma Society, The Home Depot, Liberty Mutual Group and Wellpoint, Inc. For more ...
2009 NOV 28 ... firm's many philanthropic pursuits include Duke Children's Hospital, The Leukemia and Lymphoma Society, and Mothers Against Drunk Driving. The firm has a matching-gift ...
2009 NOV 27 ... I-131 for non-Hodgkin's lymphoma and thyroid cancer, Ac-225 for acute myelogenous leukemia, and Cu-67 for lymphoma cancer," wrote G.L. Troyer and colleagues.The ...
2009 NOV 23 ... if deregulated, in the development of neoplastic disorders including chronic lymphocytic leukemia (CLL). RNAs from primary cells of 50 treatment-naive CLL patients and peripheral B cells ...
2009 NOV 27 ... in patients with a form of blood cancer, known as T-ALL or T-cell acute lymphoblastic leukemia.Abnormal NOTCH genes found in cancer patients remain in a state of constant ...
2009 NOV 23 ... for assessing compliance with maintenance therapy for childhood acute lymphoblastic leukemia,' is now available. According to recent research published in the journal...
2009 NOV 23 ... miRNA signature in MM." Unno and colleagues published their study in Leukemia & Lymphoma (Identification of a novel microRNA cluster miR-193b-365 in multiple myeloma. ...
2009 NOV 23 ... to ensure ongoing relevance." Sehn and colleagues published their study in Leukemia & Lymphoma (Early detection of patients with poor risk diffuse large B-cell lymphoma. ...
2009 NOV 23 ... from GVHD, but does not portend disease recurrence,' is newly published data in Leukemia & Lymphoma. "We analyzed the kinetics of CD3 chimerism in 120 consecutive allogeneic ...
2009 NOV 23 ... molecular markers exist that can determine where in the spectrum of chronic myeloid leukemia (CML) progression an individual patient falls at diagnosis. Gene expression profiles can ...
2009 NOV 23 ... cytokine receptors and oxidative stress were analyzed by real-time RT-PCR. Friend leukemia virus integration 1, an early hematopoiesis-related gene, showed significantly higher ...
2009 NOV 23 ... "CD52 monoclonal antibody (mAb) has been used therapeutically in lymphocytic leukemia, autoimmune disease, and organ transplantation. But the effect of CD52 mAb on intestinal ...
2009 NOV 23 ... pathway. MCTx-1 from Millepora, a homolog of DPT, is identified as a cytotoxin towards leukemia cells." "The aim of this study was to analyze DPT expression in ...
2009 NOV 23 ... "A 51-year-old male was diagnosed with chronic phase chronic myeloid leukemia (CML) in May 2005. His Sokal score at diagnosis was 0.95 and his Euro score was 1,363 ...
2009 NOV 23 ... of chemotherapy." Katsuya and colleagues published their study in Leukemia & Lymphoma (Addition of rituximab to cyclophosphamide, doxorubicin, vincristine, and ...
2009 NOV 23 ... According to a study from the United States, "In California, leukemia represents similar to 35, 5, and 2% of all cancers in children (aged 0-14), adolescents ...
2009 NOV 23 ... Shulkin and colleagues published the results of their research in Leukemia & Lymphoma (Bone and [18F]fluorodeoxyglucose positron-emission tomography/computed ...
2009 NOV 23 ... of voreloxin's synergistic and additive effects when combined with other acute myeloid leukemia (AML) treatments, supporting the current combination study and identifying potential ...
2009 NOV 23 ... 1) an ongoing Phase 1 clinical trial of TRU-016 for the treatment of chronic lymphocytic leukemia (CLL), and 2) a preclinical study demonstrating the effect of Trubion's ...
